| Patrick Giblin, OTR/L | |
|
145 Pine Haven Shores Rd, Shelburne, VT 05482-7703 | |
| (585) 704-4662 | |
| Not Available |
| Full Name | Patrick Giblin |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 145 Pine Haven Shores Rd, Shelburne, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073054342 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0720134030 (Vermont) | Primary |
| Provider Name | Powerback Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1801505847 PECOS PAC ID: 2365359932 Enrollment ID: O20230117000561 |
News Archive
Feazell & Tighe, L.L.P. announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Texas on behalf of all persons or entities who purchased or otherwise acquired the common stock of Repros Therapeutics Inc. ("Repros" or the "Company") (Nasdaq:RPRX), between July 1, 2009 and August 3, 2009, inclusive (the "Class Period").
Pregnant women, who are at increased risk of preterm birth or pregnancy loss if they develop a severe case of COVID-19, need the best possible guidance on whether they should receive a COVID-19 vaccine, according to an article by two UT Southwestern obstetricians published today in JAMA.
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
The quality of care of patients hospitalized with venous thromboembolism (VTE) significantly improved between 2005 and 2009, and researchers suggest these improvements may be due to the implementation of VTE treatment guidelines.
Children who had in-utero exposure to ischemic-hypoxic conditions, situations during which the brain is deprived of oxygen, were significantly more likely to develop attention deficit hyperactivity disorder later in life as compared to unexposed children, according to a Kaiser Permanente study published in the journal Pediatrics.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patrick Giblin, OTR/L 349 Flynn Ave, Burlington, VT 05401-5014 Ph: (585) 704-4662 | Patrick Giblin, OTR/L 145 Pine Haven Shores Rd, Shelburne, VT 05482-7703 Ph: (585) 704-4662 |
News Archive
Feazell & Tighe, L.L.P. announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Texas on behalf of all persons or entities who purchased or otherwise acquired the common stock of Repros Therapeutics Inc. ("Repros" or the "Company") (Nasdaq:RPRX), between July 1, 2009 and August 3, 2009, inclusive (the "Class Period").
Pregnant women, who are at increased risk of preterm birth or pregnancy loss if they develop a severe case of COVID-19, need the best possible guidance on whether they should receive a COVID-19 vaccine, according to an article by two UT Southwestern obstetricians published today in JAMA.
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
The quality of care of patients hospitalized with venous thromboembolism (VTE) significantly improved between 2005 and 2009, and researchers suggest these improvements may be due to the implementation of VTE treatment guidelines.
Children who had in-utero exposure to ischemic-hypoxic conditions, situations during which the brain is deprived of oxygen, were significantly more likely to develop attention deficit hyperactivity disorder later in life as compared to unexposed children, according to a Kaiser Permanente study published in the journal Pediatrics.
› Verified 9 days ago
The Philo Center Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4066 Shelburne Rd, Suite 8, Shelburne, VT 05482 Phone: 802-985-8211 Fax: 802-985-8733 | |
Kelly Marie Goodell, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Wake Robin Dr, Shelburne, VT 05482 Phone: 802-264-5140 Fax: 802-264-5152 | |
Mrs. Christine Denise Petterson, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4066 Shelburne Rd, Suite 8, Shelburne, VT 05482 Phone: 802-985-8211 Fax: 802-985-8733 | |
Jill L. Lyons, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4066 Shelburne Rd, Suite Number 8, Shelburne, VT 05482 Phone: 802-985-8211 Fax: 802-985-8733 | |
Jennifer Lundquist, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 185 Pine Haven Shores Rd, Shelburne, VT 05482 Phone: 443-928-0344 | |
Nina Z Otter, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 687 Harbor Rd, Shelburne, VT 05482 Phone: 802-318-4445 |